These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 1718702)

  • 1. Calcium antagonists in secondary prevention after myocardial infarction.
    Persson S
    Drugs; 1991; 42 Suppl 2():54-60. PubMed ID: 1718702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium antagonists and myocardial infarction.
    Hansen JF
    Cardiovasc Drugs Ther; 1991 Aug; 5(4):665-70. PubMed ID: 1888690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention with calcium channel-blocking drugs in patients after myocardial infarction: a critical review.
    Moss AJ
    Circulation; 1987 Jun; 75(6 Pt 2):V148-53. PubMed ID: 3552311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative effects of three calcium antagonists (nifedipine, verapamil and diltiazem) on hemodynamics in recent myocardial infarction].
    Sakai M; Ueda K; Nakahara K; Tsuchimochi H; Mutsushita S; Kuramoto K; Murakami M
    Kokyu To Junkan; 1985 Feb; 33(2):159-64. PubMed ID: 4001593
    [No Abstract]   [Full Text] [Related]  

  • 5. Current status of calcium channel blocking drugs after myocardial infarction.
    Moss AJ
    Eur Heart J; 1986 May; 7 Suppl A():31-4. PubMed ID: 3522237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of verapamil, nifedipine and diltiazem on experimental myocardial infarction in rats.
    Kaur AH; Singh M; Singh J; Jain K
    Indian J Exp Biol; 1985 Jan; 23(1):31-4. PubMed ID: 4018848
    [No Abstract]   [Full Text] [Related]  

  • 7. Secondary prevention with calcium antagonists after acute myocardial infarction.
    Hansen JF
    Drugs; 1992; 44 Suppl 1():33-43. PubMed ID: 1283582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Calcium antagonists in acute myocardial infarction].
    Lotto A; Massari FM; Bertoni T; Ambrosini F; Finzi A; Foresti A; Valentini R; Matta F
    G Ital Cardiol; 1988 Nov; 18(11):974-81. PubMed ID: 3073992
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcome with calcium channel antagonists after myocardial infarction: a community-based study.
    Leitch JW; McElduff P; Dobson A; Heller R
    J Am Coll Cardiol; 1998 Jan; 31(1):111-7. PubMed ID: 9426027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blockers in the management of myocardial infarction patients.
    Gheorghiade M
    Henry Ford Hosp Med J; 1991; 39(3-4):210-6. PubMed ID: 1804826
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.
    Opie LH
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):461-91. PubMed ID: 3154677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is there a role for calcium antagonists when beta-adrenergic blockade therapy is contraindicated in post-myocardial infarction?].
    Ennezat PV; Auffray JL; Darchis J; Rousselle M; Gonin X; Aubert JM; Bauchart JJ; Bauters C; Van Belle E; Asseman P
    Therapie; 2006; 61(3):191-4. PubMed ID: 16989118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium channel blockers in myocardial infarction.
    Skolnick AE; Frishman WH
    Arch Intern Med; 1989 Jul; 149(7):1669-77. PubMed ID: 2662933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium antagonists in the secondary prevention of myocardial infarction].
    Lièvre M; Nony P
    Therapie; 1993; 48 Spec No():677-83. PubMed ID: 8091354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symposium on Cardiovascular Disease and Calcium Antagonists. Introduction.
    Schwartz A
    Am J Cardiol; 1982 Feb; 49(3):497-8. PubMed ID: 7058761
    [No Abstract]   [Full Text] [Related]  

  • 16. Short-acting nifedipine and diltiazem do not reduce the incidence of cardiac events in patients with healed myocardial infarction. Secondary Prevention Group.
    Ishikawa K; Nakai S; Takenaka T; Kanamasa K; Hama J; Ogawa I; Yamamoto T; Oyaizu M; Kimura A; Yamamoto K; Yabushita H; Katori R
    Circulation; 1997 May; 95(10):2368-73. PubMed ID: 9170398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockers and mortality in elderly patients with myocardial infarction.
    Jollis JG; Simpson RJ; Chowdhury MK; Cascio WE; Crouse JR; Massing MW; Smith SC
    Arch Intern Med; 1999 Oct; 159(19):2341-8. PubMed ID: 10547174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of calcium antagonist trials in acute myocardial infarction.
    Roberts R
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III41-7. PubMed ID: 2691141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of heart rate-lowering calcium antagonists: lessons from controlled trials.
    Messerli FH; Michalewicz L
    Am Heart J; 1997 Aug; 134(2 Pt 2):S21-4. PubMed ID: 9313620
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of calcium antagonists in ventricular dysfunction.
    Josephson MA; Singh BN
    Am J Cardiol; 1985 Jan; 55(3):81B-88B. PubMed ID: 3881919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.